Loss of PTEN leads to constitutive activation of the phosphatidylinositol 3-kinases (PI3K)-AKT-mTOR signaling pathway so as to augment expression of metabolic genes regulated by SREBP1c and PPARγ in cancer proliferative cells [14,15,16]. This evidence concerns the gene PTEN and cancer.